Improved Success of Phenotype Prediction of the Human Immunodeficiency Virus Type 1 from Envelope Variable Loop 3 Sequence Using Neural Networks  by Resch, Wolfgang et al.
t
1
1
c
(
a
(
e
t
d
a
t
v
i
i
Virology 288, 51–62 (2001)
doi:10.1006/viro.2001.1087, available online at http://www.idealibrary.com onImproved Success of Phenotype Prediction of the Human Immunodeficiency Virus Type 1
from Envelope Variable Loop 3 Sequence Using Neural Networks
Wolfgang Resch,*,1 Noah Hoffman,†,1 and Ronald Swanstrom*,†,‡,2
*Department of Biochemistry and Biophysics, †Department of Microbiology and Immunology, and ‡UNC Center for AIDS Research,
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7295
Received March 1, 2001; returned to author for revision June 15, 2001; accepted July 12, 2001
We have assembled two sets of HIV-1 V3 sequences with defined epidemiologic relationships associated with experi-
mentally determined coreceptor usage or MT-2 cell tropism. These data sets were used for three purposes. First, they were
employed to test existing methods for predicting coreceptor usage and MT-2 cell tropism. Of these methods, the presence
of one basic amino acid at position 11 or 25 proved to be most reliable for both phenotypic classifications, although its
predictive power for the X4 phenotype was less than 50%. Second, we used the sequence sets to train neural networks to
infer coreceptor usage from V3 genotype with better success than the best available motif-based method, and with a
predictive power equal to that of the best motif-based method for MT-2 cell tropism. Third, we used the sequence sets to
reexamine patterns of variability associated with the different phenotypes, and we showed that the phenotype-associated
sequence patterns could be reproduced from large sets of V3 sequences using phenotypes predicted by the trained neural
network. © 2001 Academic Press
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INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) isolates
can be classified phenotypically according to their ability
to replicate and induce syncytia in MT-2 cells, a trans-
formed T-cell line (Tersmette et al., 1988), or according to
he primary coreceptor used to enter cells (Alkhatib et al.,
996; Choe et al., 1996; Deng et al., 1996; Doranz et al.,
996; Dragic et al., 1996; Feng et al., 1996). In the former
ase, the strains are termed non-syncytium-inducing
NSI) and syncytium-inducing (SI); in the latter case they
re referred to as CXCR4-using (X4) and CCR5-using
R5). These biological phenotypes are related (Bjorndal
t al., 1997), though the extent of the correlation between
he classifications and the biological significance of any
iscordance remain poorly defined. Primary infection is
lmost always limited to virus strains of R5/NSI pheno-
ype (Roos et al., 1992; Zhu et al., 1993), and X4/SI
ariants generally evolve de novo during the chronic
nfection with HIV-1. The evolution of X4/SI variants co-
ncides with a two- to fourfold accelerated loss of CD41
T cells (Koot et al., 1993; Schellekens et al., 1992; Ters-
mette et al., 1989), which in turn leads to an increased
1 These authors contributed equally to this work.
2 To whom correspondence and reprint requests should be ad-
dressed at UNC Center for AIDS Research, Lineberger Bldg., Rm
22-059, CB 7295, University of North Carolina, Chapel Hill, NC 27599-
7295. Fax: 11-(919)-966-8212. E-mail: risunc@med.unc.edu.
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probability of disease progression (Koot et al., 1993;
Richman and Bozzette, 1994).
The third variable region (V3) of the gp120 subunit of
the HIV-1 envelope protein (Env), a 35 amino acid loop
constrained by a disulfide bond, has been identified as a
major determinant of coreceptor usage and MT-2 cell
tropism (Chesebro et al., 1991; Choe et al., 1996; Cocchi
et al., 1996; Hwang et al., 1991; Takeuchi et al., 1991). A
large body of work has led to the identification of putative
sequence motifs distinguishing the X4/SI phenotypes
from the NSI/R5 phenotypes (see references in Table 1).
Rules derived from these motifs that have been em-
ployed to predict phenotypes are summarized in Table 1.
These rules, particularly the presence of a positively
charged amino acid at V3 position 11 or 25, have been
used to predict phenotype from the genotype of a virus
strain. However, the reliability of phenotype prediction
using these rules, especially for coreceptor usage, has
not been tested with large sets of epidemiologically
unrelated sequences. A reliable prediction algorithm
would be desirable for two reasons. First, a sequence-
based method of phenotype prediction as an alternative
to the more difficult experimental determination of phe-
notypes would be beneficial in the clinical setting. Sec-
ond, the large number of existing HIV-1 sequences avail-
able in public databases could be classified by V3 ge-
notype to discern potential linkage between X4-
associated changes in V3 and positions elsewhere in
gp120.
As an alternative to the design of motif-based rules for
0042-6822/01 $35.00
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5 N, ANphenotype prediction, we generated neural networks to
predict coreceptor usage or MT-2 cell tropism from the
amino acid sequence using a subset of positions in V3.
Neural networks are well suited for the detection of
complex patterns in the input data and do not require any
mechanistic assumptions about the nature of the link
between sequence and phenotype. To implement such a
neural network and to verify the reliability of the existing
phenotype prediction algorithms, we assembled two dis-
tinct sets of sequences, one with known MT-2 cell tro-
pism (NSI/SI set), and the other with known coreceptor
usage (R5/X4 set). These sets include information about
the epidemiologic relatedness of all sequences and thus
represent an improvement over sequence sets de-
scribed previously. Using these sequences, we deter-
mined that the presence of a positively charged amino
acid at positions 11 or 25 is the most reliable predictor of
the previously defined sequence motif-based rules for
both phenotypes. However, the reliability of this rule for
predicting the X4 phenotype was estimated here to be
below 50%. We have generated a neural network that has
improved reliability of coreceptor usage prediction, as
well as a separate network that performs as well as the
TABLE 1
Description of Sequence Motif-Based Rules Used to Predict
Phenotypes from V3 Sequences.
Name Ref. x4/si r5/nsi f
ethod 1 (1, 2) Basic at 11 or 25 Not x4 1
ethod 2 (3) Not r5 S or G at 11 and D or
E at 25 and GPG at
15–17
1
ethod 3 (4) Basic at one or
more of 11, 13,
19, 23, 24, or
32 and no
acidic at 25
Not x4 1
ethod 4 (3, 4) Basic at one or
more of 11, 13,
19, 23, 24, or
32 and no
acidic at 25
(Method 3)
S or G at 11 and D or
E at 25 and GPG at
15–17 (Method 2)
,1
ethod 5 (5) Net Charge $
15
Net Charge , 15 1
Note. Numbers refer to V3 amino acid positions starting with the first
ysteine, letters represent the single letter amino acid code. Method 4
xcludes approximately 30% of all sequences that are predicted to
ave different phenotypes by the two rules. Dual-tropic virus strains
R5X4) are considered to be X4 for the purposes of this analysis. Ref. 1,
e Jong et al., 1992; 2, Fouchier et al., 1995; 3, Xiao et al., 1998; 4, Milich
t al., 1997; 5, Fouchier et al., 1992. r5/nsi, x4/si, rules defining the r5/nsi
nd x4/si phenotypes, respectively. f, fraction of sequences assigned
n unequivocal phenotype by the prediction algorithm.
2 RESCH, HOFFMA11/25 rule for the prediction of the NSI/SI phenotype.
Moreover, we present a more detailed statistical analysisof V3 sequence determinants associated with the two
phenotypes.
RESULTS AND DISCUSSION
Construction of V3 sequence sets with experimentally
determined coreceptor usage or MT-2 cell tropism
and known epidemiologic relatedness
To test the performance of existing rules for the infer-
ence of phenotypes from V3 sequences and to generate
neural networks for phenotype prediction, we assembled
two sequence sets, one with known coreceptor usage
(R5/X4 sequence set), and the other with known MT-2
cell tropism (NSI/SI sequence set). The ability to employ
the CXCR4 coreceptor was treated as sufficient for the X4
phenotype (i.e., dual-tropic viruses are classified as X4).
For both sets, the epidemiologic relationships among the
sequences were determined. The sources and pheno-
types of all unique sequences are summarized in Table
2. The R5/X4 set contains both published and unpub-
lished sequences. For the unpublished sequences, we
obtained descriptions of the phenotypes and the source
of the indicated sequences. The sequence sets repre-
sent the largest collection of unrelated sequences with
known phenotypes described to date, although the pau-
city of X4 and SI sequences is still a limitation. In this
discussion we will use uppercase R5/X4/NSI/SI to refer
to experimentally determined phenotypes, while lower-
case letters (e.g., r5, nsi) indicate phenotypes inferred
from V3 sequence.
To compare groups of sequences with predicted phe-
notypes to groups with experimentally determined phe-
notypes and to estimate the frequency of x4-associated
sequence, we also assembled a database containing
1997 unique V3 peptide sequences isolated from differ-
ent individuals. From this set we estimated the frequency
of X4- or SI-associated sequences to be approximately
0.15 using all classification methods available to us; this
value is used as an estimate for the frequency of X4-
associated sequences in the calculations of reliability.
The presence of a positively charged amino acid at
position 11 or 25 (method 1) is the best available
motif-based predictor of coreceptor usage and MT-2
cell tropism
We first determined the performance of the previously
used rules (Table 1) for predicting R5/X4 or NSI/SI phe-
notypes. To test these rules, sequences were chosen at
random from each of the sequence sets such that no two
sequences associated with the same phenotype were
derived from the same patient, and the predicted pheno-
types of these sequences were compared to the exper-
imental phenotypes. This strategy minimizes the con-
D SWANSTROMfounding effects of epidemiologic relatedness among the
test sequences. To fully sample the set of sequences,
e
8
FROMthis analysis was repeated 100 times to include each
sequence in the test set at least once. The average 2 3
2 contingency table summarizing the performance of the
five sequence rules is shown in Table 3, with several
corresponding measures of performance. Here, the
specificity of the rules is the most important measure of
performance, as it represents the fraction of R5 or NSI
sequences that are misclassified as X4 or SI. Since X4 or
SI sequences are underrepresented in the set of all
published sequences, even small deviations of specific-
ity from 1 can lead to a considerable contamination of
the predicted x4 or si sequence set with R5 or NSI
sequences. In addition, the phi coefficient is informative
as a measure of correlation between the algorithm re-
sults and the experimental phenotypes.
TABLE 2
Source and Associated Phenotype of Sequence Sets
(A) Unique R5/X4 sequences collected
Sequences
total X4 R5 Patients Reference
83 31 52 59 (1)
17 0 17 13 (2)
11 4 7 3 (3)
6 6 0 3 (4), (5)
11 3 8 11 (6)
31 2 29 31 (7)
57 1 56 57 (8)
216 47 169 177
UnrelatedR5/X4sequences
181 31 150 177
(B) Unique NSI/SI sequence set
Sequences
Patients Referencetotal SI NSI
10 2 8 5 (1)
11 3 8 8 (9)
28 12 16 22 (10)
199 48 151 63 (11)
9 5 4 8 (12)
257 70 187 106
UnrelatedNSI/SIsequences
124 40 84 106
Note. 1, GenBank; 2, Chan et al., 1999; 3, Singh et al., 1999; 4, Nelson
t al., 2000; 5, Michael et al., 1998; 6, Lathey et al., 2000; 7, Li et al., 1999;
, Zhang et al., 1998; 9, Bhattacharyya et al., 1996; 10, Cornelissen et al.,
1995; 11, Fouchier et al., 1995; 12, Fouchier et al., 1992.
INFERRING PHENOTYPEFor the R5/X4 set, methods 1 and 2 display the great-
est specificity, although method 1 is the more sensitivetest (Table 3A). If specificity is considered the most
important of the performance measures, method 1, using
the presence of a positively charged amino acid at either
position 11 or 25, should be considered the best se-
quence-motif-based method currently available for the
determination of coreceptor usage. Note, however, that
this method has an estimated reliability of X4 prediction
of only 0.48 based on the estimated frequency of 0.15 of
X4 associated sequences in the set of all available se-
quences. Method 1 also outperforms all other sequence
rules for NSI/SI phenotype prediction as measured by
both specificity and the phi coefficient (Table 3B), with a
reliability of SI phenotype prediction of approximately
0.85. Although method 4 performs well for both pheno-
types, it fails to classify 30% of all sequences and is thus
a poor choice for phenotype prediction. Method 5, which
requires a positive charge of at least 5 for x4 or si
classification, shows a phi association coefficient of 0.77
with the NSI/SI phenotype. It should be noted that the
overall performance of all sequence rules is lower for the
R5/X4 sequence set than for the NSI/SI sequences.
The overall reliability of all sequence motif-based
methods for phenotype inference, especially for corecep-
tor usage prediction, was limited. This indicates that
simple sequence motifs encompassing a few amino acid
positions in V3 may not be sufficient to determine core-
ceptor usage reliably, although there was a strong asso-
ciation between the accumulation of positive charges,
particularly at positions 11 and 25, and MT-2 cell tropism.
The differential performance of all five methods applied
to the two data sets is an indication that the two pheno-
types may not be synonymous. We could not formally
exclude the possibility that selection bias contributed to
the observed differences between the two phenotypic
classifications, especially because of the small number
of SI and X4 sequences. Nevertheless, we have chosen
to treat these two phenotypes as only partially overlap-
ping and analyze them separately. In the following anal-
yses we selected method 1 as the standard to which we
compared the performance of the neural networks.
Neural networks infer coreceptor usage from V3
sequence with greater reliability than sequence
motifs
To devise a more reliable method for the prediction of
coreceptor usage and the NSI/SI phenotype, we trained
and tested neural networks on each of the two sequence
sets. Neural networks were generated and trained using
epidemiologically unrelated subsets of sequences ran-
domly chosen from the sequence sets as described in
the previous section. Training was done on half of the
randomly chosen epidemiologically unrelated se-
quences, and performance was assessed on the other
53HIV-1 V3 GENOTYPEhalf. Thus, the set of test sequences did not overlap the
sequences presented to the network during training.
f, phi
p
5Some R5 sequences were discarded from the R5/X4 data
set prior to training to increase the proportion of X4
sequences. Several networks were trained and the net-
T
Performance of Sequence Motif-Based Phenotype Pred
(A) R5/X4
Rule
2 3 2 Contingency table
fR5 X4
Method 1 r5 135 14 1
x4 15 17
Method 2 r5 135 17 1
x4 15 14
Method 3 r5 92 6 1
x4 58 25
Method 4 r5 92 6 0.7
x4 15 14
Method 5 r5 130 10 1
x4 20 21
(B) NSI/S
Rule
2 3 2 Contingency table
fNSI SI
Method 1 nsi 82 6 1
si 2 34
Method 2 nsi 79 17 1
si 5 23
Method 3 nsi 54 1 1
si 30 39
Method 4 nsi 54 1 0.7
si 5 23
Method 5 nsi 78 7 1
si 6 33
Note. Lower- and upper-case letters indicate predicted and experim
performance for the NSI/SI sequences. Note also that the specificity
sequences. In the contingency table the underlined numbers indicate c
scores. f, fraction of sequences for which the method could provide
sequences; specificity, fraction of correctly classified R5 sequences;
redicted x4 or si phenotype to actually be X4 or SI, respectively.
4 RESCH, HOFFMAwork with the best performance on the test set was
chosen for further analysis. Performance of the bestnetworks for both phenotypes was compared to the per-
formance of method 1 on identical sequence subsets
(Table 4). The best networks were termed “R5/X4 net-
Methods for the R5/X4 and the NSI/SI Sequence Sets
nce set
Sensitivity Specificity f X4 reliability
0.53 0.90 0.43 0.48
0.45 0.90 0.36 0.44
0.81 0.61 0.32 0.27
0.71 0.86 0.49 0.47
0.66 0.87 0.48 0.47
nce Set
Sensitivity Specificity f SI reliability
0.84 0.97 0.84 0.85
0.58 0.94 0.58 0.63
0.96 0.65 0.57 0.32
0.94 0.92 0.83 0.67
0.83 0.93 0.77 0.68
determined phenotypes, respectively. Note the general trend to better
jor determinant for performance due to the abundance of R5 or NSI
redictions; in the other columns underlined numbers indicate the best
mbiguous classification; sensitivity, fraction of correctly classified X4
coefficient of association; reliability, probability of a sequence with
D SWANSTROMABLE 3
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N, ANwork” and “NSI/SI network” and are available upon re-
quest.
o ean o
rThe best neural networks had greater specificities and
phi coefficients than method 1 on training and test sets
for both coreceptor usage and NSI/SI phenotypes (Table
4). The improvement over method 1 for the NSI/SI set,
however, was marginal. Note that the performance of the
networks on the test set was lower than the performance
on the training set for networks trained on the R5/X4
sequences. This is most likely due to the limited number
of available sequences and the greater relative abun-
dance of R5 sequences. The mean reliability for X4 pre-
diction of the R5/X4 neural network was 0.69 for 100
subsets of unrelated sequences, a considerable im-
provement over the reliability of 0.48 achieved by method
1. The mean reliability of the NSI/SI neural network was
0.80, comparable to the 0.84 achieved by the 11/25 motif
of method 1. The lower performance of the networks on
FIG. 1. Distribution of amino acids at positions 2 to 34 in HIV-1
epidemiologically unrelated sequences obtained from the Los Alamo
T
Performance of Two Neural Networks on Their Respective Test and
the Presence of a Basic Amino Acid at Either Po
R5/X4 S
Algorithm
Training Set
Sens Spec f S
Method 1 0.60 0.89 0.51 0
R5/X4 network 0.80 0.98 0.82 0
NSI/SI
Method 1 0.85 1.00 0.89 0
NSI/SI network 0.95 1.00 0.96 0
Note. Sens, sensitivity; spec, specificity; f, phi coefficient of associat
f the prediction algorithm. Overall performance is measured as the m
espective data sets.
INFERRING PHENOTYPEcontaining the corresponding amino acid. Only amino acids that occurred at le
shown above the line. Uppercase letters are single letter amino acid codes;the test sets compared to the training sets was due to a
reduction in specificity. Networks trained to infer core-
ceptor usage have a reduced, though still significant,
ability to infer the NSI/SI phenotype and vice versa (data
not shown).
We can conclude that the neural network approach
achieves a reliability similar to method 1 for prediction of
NSI/SI phenotypes, indicating that MT-2 cell tropism may
be largely determined by changes at positions 11 and 25
in the V3 region of HIV-1 Env. However, the prediction of
coreceptor usage from V3 sequence can be enhanced
considerably by a neural network, suggesting that the
sequence patterns underlying this phenotype may be
more complex than the patterns characterizing the
NSI/SI phenotype. The predictive power of the network
for the X4 phenotype still remains below 0.7. This could
V3. The sequence set used for this analysis contained n 5 1997
Sequence Database. Numbers denote the percentage of sequences
ng Sets Compared with the Performance of Method 1, Which Uses
11 or 25 of V3 to Classify X4 and SI Sequences
ce Set
Test Set Overall
Spec f Sens Spec f
0.87 0.42 0.53 0.90 0.43
0.89 0.67 0.75 0.94 0.68
ce set
0.90 0.75 0.84 0.97 0.84
0.93 0.89 0.90 0.96 0.87
te that the critical parameters are the phi coefficient and the specificity
f n 5 100 subsets of unrelated sequences drawn at random from the
55HIV-1 V3 GENOTYPEclade B
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rbe due either to an insufficient number of sequences
used to train the neural network or the existence of
coreceptor usage determinants outside of V3. The latter
possibility is supported by the reported correlations be-
tween other regions of Env with coreceptor usage, in
particular, the V1/V2 and C4 regions (Andeweg et al.,
1993; Carrillo and Ratner, 1996; Cornelissen et al., 1995;
Groenink et al., 1993; Ly and Stamatatos, 2000; Milich et
al., 1997; Shieh et al., 2000; Sullivan et al., 1993). The
importance of regions outside of V3 is also suggested by
the identification of identical V3 sequences found in
viruses with different phenotypes (R. Collman, personal
communication; Groenink et al., 1992; Singh et al., 1999;
Singh and Collman, 2000).
Distinctive patterns of sequence entropy are found
among sequences associated with R5 or X4
phenotypes and can be reproduced in larger data
sets using phenotype prediction
Env regions classically described as “variable” contain
both positions that are highly conserved and those that
experience frequent amino acid substitution (for exam-
ple, see Fig. 1 and Yamaguchi-Kabata and Gojobori,
2000). In addition it has previously been shown that the
overall variability is lower in NSI/R5 sequences than
SI/X4 sequences (Chesebro et al., 1992; Milich et al.,
FIG. 2. Comparison of sequence entropy at positions 2 through 34 o
striking change of pattern between positions 18 and 23 (indicated by a
and 32. The HIV-1 clade B consensus sequence of the V3 region is sh
than within the R5 sequences. *P # 0.01; **P # 0.005; ***P , 0.001.
56 RESCH, HOFFMA993). We used sequences of known phenotype both to
eexamine variability at each position of V3 and to show
i
lhat phenotyping algorithms can reproduce similar pat-
erns using V3 sequences retrieved from GenBank.
Entropy was used as a measure of the position-by-
osition variability of the complete R5/X4 data set (n 5
16). The data set was divided into R5 and X4 sequences,
nd the entropy of the sequence alignment was deter-
ined for every position in V3 among sequences belong-
ng to each of the two phenotypes (Fig. 2). Permutation
ests were used to determine the significance of the
ifference in entropy between the sequences associated
ith the two phenotypes at each position. On average,
5 sequences had lower entropy at most V3 positions.
nexpectedly, position 18 was significantly less variable
mong X4 sequences, suggesting a functional role for
his position in CXCR4 usage. Another difference be-
ween the two phenotypes is the disappearance of a
attern of alternating high and low entropies at positions
8 through 23 among X4 sequences. The increase in
ntropy in X4 sequences is greatest for positions 8, 11,
5, 32, and 27. From our analysis it is unclear whether the
bserved differences in entropy between the two pheno-
ypes are directly linked to the coreceptor usage change
r are confounded by the changes in the host environ-
ent accompanying the phenotypic switch.
To determine whether the phenotype prediction algo-
ithms would reproduce the entropy patterns character-
r the R5/X4 sequence set divided into X4 and R5 sequences. Note the
ar). Other significant changes were detected at positions 8, 11, 25, 27,
low the graph. The overall entropy is higher within the X4 sequences
D SWANSTROMf V3 fo
gray b
own be
N, ANstic for each phenotype, 1997 epidemiologically un-
inked sequences retrieved from GenBank were divided
ner. Nointo groups by their predicted phenotypes and analyzed
as described above. We used the sequence motif-based
method 1 and the R5/X4 neural network for coreceptor
usage prediction. In Fig. 3, the entropies of the se-
quences with the predicted phenotypes are shown in
comparison with the entropies measured in the R5/X4
sequence set. Overall, the entropy pattern observed
among sequences of either phenotype is reproduced
well by both algorithms. Thus, both phenotype prediction
algorithms, despite their performance differences and
their different approaches, generate similar entropy pat-
terns. Note that the two different algorithms appear to
FIG. 3. Reproduction of entropy patterns in V3 sequences by the R5/X
sequences with predicted phenotypes. Of these, 362 were predicted to
(11/25). Note that lowercase letters indicate inferred phenotypes and u
(B) X4 and x4 sequences. Below the graphs the consensus sequence fo
the entropy calculated for the coreceptor sequence set in a similar man
phenotypes between positions 18 and 23.
INFERRING PHENOTYPEresult in similar deviations from the entropy of se-
quences of known phenotype (e.g., at position 5). Thisdeviation points to a possible selection bias in the small
set of sequences known to use the CXCR4 coreceptor.
The R5 to X4 and NSI to SI switches are associated
with distinct but similar changes in amino acid
composition at several positions in V3
Numerous studies have reported linkage between vi-
ral phenotype and changes in the amino acid composi-
tion at specific positions in V3 (Carrillo and Ratner, 1996;
de Jong et al., 1992; Hung et al., 1999; Milich et al., 1997;
Shioda et al., 1992). However, either the relatedness,
limited number of sequences, or the unavailability of
al network and sequence motif-based method 1. There were n 5 1997
by the neural net and 298 sequences were classified x4 by method 1
se letters indicate experimental phenotypes. (A) R5 and r5 sequences.
clade B V3 is shown. At several positions both algorithms deviate from
te that both algorithms show the same shift of pattern for the different
57HIV-1 V3 GENOTYPE4 neur
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FROMexperimentally determined phenotypes limited the power
of those studies to describe the significance of the re-
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5ported correlations. Therefore we reexamined the rela-
tionship between phenotype and amino acid composi-
tion using both the R5/X4 and the NSI/SI data sets. To
minimize the confounding effects of epidemiologic relat-
edness, a single subset of unrelated sequences from
each of the R5/X4 (n 5 124) and NSI/SI (n 5 124) data
ets was analyzed to examine differences in amino acid
omposition between the X4/R5 and NSI/SI phenotypes,
espectively.
The statistical significance of the phenotype-associ-
ted differences in the frequencies of amino acids at
ach position was determined using a permutation test,
hereby the difference in abundance of each amino acid
t each position was compared to the differences ob-
erved in 1000 random partitions of the same data set
ithout respect to phenotype. The probability P that the
bserved difference is due to chance can be estimated
s the number of times the same or a more extreme
ifference was observed in the random sequence parti-
FIG. 4. Characteristic differences in amino acid composition associat
as chosen at random from both the R5/X4 and the NSI/SI sequenc
ositions that showed at least one significant difference between one o
re shown here. The significance level of the differences is indicated clo
y a permutation test. Differences assigned a significance level of P ,
est. Note that the amino acid composition at position 25 is shown at
8 RESCH, HOFFMAions divided by the number n 5 1000 of random parti-
ions.
o
sFigure 4 summarizes all V3 positions that showed a
tatistically significant (P , 0.01) difference for one of the
henotype pairs either in at least one amino acid or in
he entropy of the sequence groups (see previous sec-
ion). As expected, amino acids at positions 11 and 25
ere present at significantly different proportions in each
f the phenotype pairs. At position 11, R, but not K, was
ignificantly enriched among SI and X4 sequences. At
osition 25, D was significantly underrepresented in SI
nd X4 sequences, whereas K was overrepresented.
hese observations indicate that the acidic (D and E) and
asic (R and K) residues, respectively, are not entirely
quivalent at these positions. The generally lower abun-
ance of R and K at positions 11 and 25, respectively, in
4 sequences compared to SI sequences also helps to
xplain the reduced reliability of the 11/25 rule for core-
eptor usage prediction.
Several other changes were either restricted to, or
uch more apparent in, a single data set. The frequency
the R5/X4 and NSI/SI phenotypes. A single set of unrelated sequences
and divided according to phenotype. The amino acid composition at
enotype pairs for either the distribution of an amino acid or the entropy
e bars that display the difference. Significance levels were determined
ell outside the support of the reference distribution for the permutation
ler scale. A–Y: amino acids; g: gap.
D SWANSTROMed with
e sets
f the ph
se to th
N, ANf 11S was higher among X4 sequences (41%) than SI
equences (13%). Significant shifts from F to V at position
FROM20, from G to E at 24, and a trend from T to A at 23 were
apparent only in the NSI/SI data set. Overall, the pattern
changes accompanying a switch from R5 to X4 or NSI to
SI are similar, though not identical (see below). This is
further evidence for the disparity between the two phe-
notypic classifications. The less dramatic nature of
changes accompanying the R5 to X4 switch compared to
the NSI to SI switch in these data sets raises the possi-
bility that the X4 phenotype could include the early
events in a phenotypic change pathway in which the SI
phenotype represents a late stage. Alternatively, this
observation could be explained by the inclusion of V3
sequences associated with the ability to use both core-
ceptors in the X4 set. These sequences may fall along a
continuum from more X4-like to more R5-like and the
resulting contamination of the X4 sequence set may
therefore obscure greater differences between the pure
X4 and R5 sequences.
A common feature among several positions differing in
composition between phenotypes was a shift away from
the majority amino acid without a change in consensus
among both X4 and SI sequences. This underrepresen-
tation of the consensus amino acid was significant at a
level of P , 0.01 in both the R5/X4 and the NSI/SI data
sets for three positions (8, 11, and 19). Significance was
achieved at other positions within either the R5/X4 data
set alone (13, 27, 32), or the NSI/SI data set alone (7, 20,
24), although the overall trend at each of these positions
was similar in both data sets. The opposite trend, a shift
away from the consensus amino acid among R5/NSI
sequences, was observed at position 18, though this
trend achieved significance only in the R5/X4 data set.
An actual change in the majority amino acid was ob-
served at two positions. The consensus at position 22
changed from A among R5 and NSI sequences to T
among X4 and SI sequences, though again the shift was
only significant in the coreceptor set. At position 25, the
consensus amino acid changed from D to K in the NSI/SI
data set. Although this trend was present in the R5/X4
set, the magnitude of the change was smaller and did
not result in a change in consensus.
The characteristic differences of amino acid compo-
sition between the R5 and X4 phenotype can also be
employed as another indirect measure for the perfor-
mance of the R5/X4 neural network. To this end, we
randomly selected sequences with inferred x4 or r5
phenotypes from a large set of unrelated sequences
obtained from GenBank and compared amino acid
composition at each V3 position in these sets to se-
quences with experimentally determined phenotypes.
This analysis showed that sequence sets with x4 phe-
notype inferred using the R5/X4 neural networks
showed few statistically significant differences when
compared to a set of sequences with experimentally
INFERRING PHENOTYPEdetermined phenotypes. However, using method 1 to
infer the x4 phenotype resulted in more differencesbetween the x4 and the X4 sets, especially at positions
11 and 25 (data not shown). This indicated that the
R5/X4 neural network can extract sequences from the
publicly available databases that, as a group, are
largely indistinguishable from sequences with experi-
mentally determined phenotypes.
Summary
To analyze and compare the reliability of existing,
sequence motif-based algorithms and new, neural net-
work-based algorithms for predicting phenotype, we
have assembled sets of HIV-1 V3 sequences with known
coreceptor usage or MT-2 cell tropism. Of the five rules
examined, the presence of a basic amino acid at position
11 or 25 emerged as the best sequence motif-based
predictor of both phenotypes, although its reliability for
predicting X4 phenotypes fell below 0.50. We have de-
veloped a neural network that predicts CXCR4 corecep-
tor usage with a considerably higher reliability (0.69).
We can draw several general conclusions from this
work. First, the reliability of even the best predictors of
phenotype are probably not yet sufficient for use in a
clinical setting. However, V3 genotype can be used to
recapitulate patterns of amino acid variability linked to
the phenotypes on a population level. In this respect, the
neural network should be useful for examining large
numbers of sequences to identify correlations between
predicted phenotype and sequence changes outside of
V3, and, as such, represents a substantial improvement
over other algorithms. Finally, the difficulty of predicting
coreceptor usage using V3 sequence alone reinforces
the potential for the existence of phenotypic determi-
nants that lie elsewhere in gp120 and highlights the need
for their identification.
MATERIALS AND METHODS
Sequences
V3 sequences associated with known coreceptor us-
age (R5/X4 data set). To generate the R5/X4 data set, V3
sequences representing molecular or biological HIV-1
clones with known coreceptor usage were collected
from the Los Alamos HIV Sequence Database (http://hiv-
web.lanl.gov) and from published studies. Sequences
derived from uncloned isolates were not considered.
Unpublished sequences with phenotypes described in
Singh et al. (1999), Lathey et al. (2000), and Zhang et al.
(1998) were generously provided by the authors. Single
representatives of entries with identical V3 peptide se-
quences were chosen arbitrarily and are described in
Table 2. Information about the epidemiologic relationship
between the sequences was either provided by the cor-
responding authors or inferred from cited literature and
59HIV-1 V3 GENOTYPEdendrograms (using the program PileUp in the Wiscon-
sin program suite of the Genetics Computer Group) con-
t
s
s
1
o
1
w
p
H
t
h
O
S
i
s
i
a
a
r
A
p
n
o
t
a
c
u
a
s
o
T
V
m
t
s
S
w
p
N, ANstructed using the largest common nucleotide fragment
available from GenBank (255 nucleotides, data not
shown). Closely related clusters of sequences from sub-
jects sharing common sources of transmission were
classified as originating from a single patient. Of the 47
sequences classified as X4 in this set, 18 used CXCR4
exclusively; the remainder retained some ability to utilize
CCR5. Note that both sequence sets contain epidemio-
logically related sequences. However, all analyses were
done using randomly chosen subsets of the R5/X4 set
such that no two sequences of the same phenotype were
derived from the same subject. This resulted in a subset
of 181 of the original 216 R5/X4 sequences, which was
used in most analyses. For some analyses a smaller
subset was created by omitting some R5 sequences to
increase the fraction of X4 sequences in the total set.
V3 sequences associated with known MT-2 cell tro-
pism (NSI/SI data set). A separate set of V3 sequences
from either molecular clones, biological clones, or viral
isolates with known MT-2 cell tropism was also assem-
bled (Table 2). Again, after all sequences were collected,
only one of each set of identical entries was retained.
Because in many cases only V3 peptide sequences were
available, phylogenetic trees were not constructed. In-
stead, relatedness of sequences was inferred entirely
from epidemiologic information available in GenBank
records or in cited publications. Again, subsets of se-
quences of size n 5 124 were chosen at random from the
otal of 257 sequences in the NSI/SI set such that no two
equences of identical phenotype were derived from the
ame subject.
V3 sequences with unknown phenotype. A set of n 5
997 V3 sequences in which no two sequence entries
riginated from the same patient was selected from over
1,000 V3 sequences retrieved from GenBank. This set
as chosen using descriptions of V3 sequences com-
osed largely of information provided by the Los Alamos
IV Sequence Database (B. Foley, personal communica-
ion).
All three sequence sets are available from the authors at
ttp://cancer.med.unc.edu/swanstromlab/resources.html.
nly HIV-1 clade B sequences were considered.
equence alignments and sequence selection
Alignments of V3 sequences were constructed by mak-
ng serial pairwise alignments with the Clade B V3 consen-
us. For each aligned sequence, amino acids representing
nsertions with respect to the consensus were discarded
nd gaps were retained. Alignments were performed using
Java implementation of the Needleman–Wunsch algo-
ithm (Needleman and Wunsch, 1970).
nalysis of algorithm performance
60 RESCH, HOFFMAUppercase letters indicate experimentally determined
henotypes (e.g., X4, SI), whereas lowercase letters de- pote inferred phenotypes (e.g., x4, si). The performance
f the sequence classification methods was measured in
erms of sensitivity, specificity, reliability, and the associ-
tion coefficient phi (f). The sensitivity of the algorithm
an be determined as P(x4 u X4) 5 [P(x4 ø X4)]/P(X4) and
the specificity as P(r5 u R5) 5 [P(r5 ø R5)]/P(R5). These
measures reflect the fraction of correctly predicted se-
quences for each of the two phenotypes. Numbers range
from 0 to 1, with 1 being complete agreement between
the predicted and actual phenotypes. By Bayes’ theorem,
the reliability (positive predictive power), which is the
probability that a sequence predicted to be x4 is in fact
X4, was calculated as P(X4 u x4) 5 [P(x4 u X4)P(X4)]/[P(x4
X4)P(X4) 1 P(x4 u R5)P(R5)]. The phi coefficient of as-
sociation was calculated as f 5 =X2/n, where X2 is the
test statistic from a chi-squared test of the 2 3 2 table
and n is the total sample size.
Neural networks
Neural networks were fully connected feed-forward
networks with 16 sigmoidal input nodes, three hidden
sigmoidal nodes, and one linear output node. All nodes
had a bias. The V3 amino acid positions 5, 7, 8, 10, 11, 13,
18–22, 24, 25, 27, and 32 plus the overall charge of the V3
loop were presented to the network. These positions
were chosen based on both statistical analysis and em-
pirical approaches. Amino acids and gaps were encoded
numerically by consecutive numbers from 1 to 21 on the
order of D, E, C, N, F, T, M, S, Y, Q, GAP(g), W, I, V, L, A,
G, P, H, K, R. Several other number assignments were
tried and did not improve network performance. Net-
works and analysis tools were implemented in Matlab
(MathWorks). Training was done using a Bayesian regu-
lation modification of backpropagation and started with
random weights (MacKay, 1992). Learning rate was set to
h 5 0.05. The training target used values of 0 for R5/NSI
nd 1 for X4/SI. We assigned the x4 phenotype to any
equence that achieved a network score of greater than
r equal to an empirically determined cutoff value of 0.4.
he distribution of values at each amino acid position of
3 used as an input node was normalized using the
ean and standard deviation of the corresponding posi-
ion in a set of n 5 11,471 numerically encoded V3
equences from GenBank.
tatistical analysis
Amino acid (aa) composition at each position in V3
as compared between R5 and X4 sequences (in pro-
ortions of P(R5) and P(X4), respectively) in a subset of
epidemiologically unrelated sequences from the R5/X4
data set using a permutation test. At each position i, a
significance test based on the normal approximation of
the binomial distribution was used to generate a Z score,
D SWANSTROMZXR(aaij), describing the magnitude of the difference in the
roportion of sequences in the X4 and R5 groups con-
d
w
Z
r
a
s
z
C
w
t
r
C
C
C
C
d
D
D
FROMtaining a given amino acid, j. Only amino acids repre-
senting at least 10% of either R5 or X4 sequences at a
position were considered. For each aaij, a reference
distribution of R 5 1000 Z scores was created by ran-
domly casting sequences into groups A and B, such that
P(Ak) 5 P(X4), and P(Bk) 5 P(R5) for all k [ [1, . . . , R], and
calculating a new Z score, ZAB(aaijk). The probability that
a difference in the proportion of an aa j at position i is
ue to chance can thus be represented by p # C/R,
here C is the smaller of the number of events in which
ZXR(aaij) # ZAB(aaijk), or ZXR(aaij) $ ZAB(aaijk), 1 # k # R. If
XR(aaij) falls beyond the maximum or minimum of the
eference distribution (i.e., C 5 0), the probability is p ,
1/R. The same procedure was used to compare the
amino acid composition between SI and NSI sequences
at each position in an alignment of epidemiologically
unrelated sequences from the MT-2 data set.
Entropy
Entropy at each V3 position was calculated from an
alignment of sequences according to Shannon as H(i) 5
2Os5121 P(si)log2P(si), with P(si) being the frequency of
each amino acid s at position i in the alignment (Shan-
non, 1948). Gaps were assigned a separate, twenty-first
character. The maximum entropy of Hmax 5 log2 21 ’ 4.4
t any position is reached in the event of equal repre-
entation of all 21 characters. The minimal entropy of
ero is reached for positions with 100% conservation.
ustom software
All custom programs, including the trained neural net-
orks for phenotype inference, are available from
he authors at http://cancer.med.unc.edu/swanstromlab/
esources.html.
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